A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit at Women’s College Hospital, finds risk-reducing mastectomies (RRM) in women with a BRCA1 or BRCA2 genetic variant, significantly reduces the risk of being diagnosed with breast cancer and lowers the probability of death.
AbbVie makes second deal in a week, betting $8.7B in cash on CNS biotech Cerevel
AbbVie said Wednesday evening it plans to pay $8.7 billion to acquire neuroscience drugmaker Cerevel Therapeutics in a deal that comes just six days after
December 7, 2023